Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A
X. Rosa, Mercedes Prudencio, Yuka Koike, et al.
Nature (2022) Vol. 603, Iss. 7899, pp. 124-130
Open Access | Times Cited: 337

Showing 1-25 of 337 citing articles:

TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
Anna‐Leigh Brown, Oscar G. Wilkins, Matthew J. Keuss, et al.
Nature (2022) Vol. 603, Iss. 7899, pp. 131-137
Open Access | Times Cited: 313
Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies
Michael W. Baughn, Ze’ev Melamed, Jone López‐Erauskin, et al.
Science (2023) Vol. 379, Iss. 6637, pp. 1140-1149
Open Access | Times Cited: 115
Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis
Sai Zhang, Johnathan Cooper‐Knock, Annika K. Weimer, et al.
Neuron (2022) Vol. 110, Iss. 6, pp. 992-1008.e11
Open Access | Times Cited: 97
Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy
Naoki Suzuki, Ayumi Nishiyama, Hitoshi Warita, et al.
Journal of Human Genetics (2022) Vol. 68, Iss. 3, pp. 131-152
Open Access | Times Cited: 93
Alternative splicing in neurodegenerative disease and the promise of RNA therapies
David Nikom, Sika Zheng
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 8, pp. 457-473
Closed Access | Times Cited: 81
Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD
Sahba Seddighi, Yue Qi, Anna‐Leigh Brown, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 734
Open Access | Times Cited: 74
Antisense Oligonucleotides for the Study and Treatment of ALS
Benjamin D. Boros, Kathleen M. Schoch, Collin J. Kreple, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 4, pp. 1145-1158
Open Access | Times Cited: 72
Dynamic mapping of proteome trafficking within and between living cells by TransitID
Wei Qin, Joleen S. Cheah, Charles Xu, et al.
Cell (2023) Vol. 186, Iss. 15, pp. 3307-3324.e30
Open Access | Times Cited: 72
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Katherine E. Irwin, Pei Jasin, Kerstin E. Braunstein, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 382-393
Open Access | Times Cited: 62
The era of cryptic exons: implications for ALS-FTD
Puja R. Mehta, Anna‐Leigh Brown, Michael E. Ward, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 59
Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects
Michael J. Workman, Ryan G. Lim, Jie Wu, et al.
Neuron (2023) Vol. 111, Iss. 8, pp. 1191-1204.e5
Open Access | Times Cited: 52
Molecular subtypes of ALS are associated with differences in patient prognosis
Jarrett Eshima, Samantha O’Connor, Ethan Marschall, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Katherine E. Irwin, Udit Sheth, Philip C. Wong, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease
Ana Rita Agra de Almeida Quadros, Zhaozhi Li, Xue Wang, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 23
TDP-43-stratified single-cell proteomics of postmortem human spinal motor neurons reveals protein dynamics in amyotrophic lateral sclerosis
Amanda J. Guise, Santosh A. Misal, Richard H. Carson, et al.
Cell Reports (2024) Vol. 43, Iss. 1, pp. 113636-113636
Open Access | Times Cited: 23
hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS)
Hannah E. Salapa, Patricia A. Thibault, Cole D. Libner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 20
TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia
Jordan D. Marks, Virginia Estades Ayuso, Yari Carlomagno, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 730
Open Access | Times Cited: 17
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Marián Hruška-Plocháň, Vera I. Wiersma, A Betz, et al.
Nature (2024) Vol. 626, Iss. 8001, pp. 1073-1083
Open Access | Times Cited: 16
Cell state-dependent allelic effects and contextual Mendelian randomization analysis for human brain phenotypes
Alexander Haglund, Verena Zuber, Maya Abouzeid, et al.
Nature Genetics (2025)
Open Access | Times Cited: 3
RNA dysregulation in neurodegenerative diseases
Yini Li, Shuying Sun
The EMBO Journal (2025) Vol. 44, Iss. 3, pp. 613-638
Open Access | Times Cited: 3
Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics
Sarah Mizielinska, Guillaume M. Hautbergue, Tania F. Gendron, et al.
The Lancet Neurology (2025) Vol. 24, Iss. 3, pp. 261-274
Closed Access | Times Cited: 3
Aberrant splicing in Huntington’s disease accompanies disrupted TDP-43 activity and altered m6A RNA modification
Thai B. Nguyen, Ricardo Miramontes, Carlos Chillón-Marinas, et al.
Nature Neuroscience (2025)
Open Access | Times Cited: 2
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 63
Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy
Kelsey L. Krus, Amy Strickland, Yurie Yamada, et al.
Cell Reports (2022) Vol. 39, Iss. 13, pp. 111001-111001
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top